Arrowhead Research Corporation
Symbol: ARWR (NASDAQ)
35.31
▲ (2.04%) 0.706
Company Description:
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Key Stats
- Today's Open: $35
- Today's High: $35.36
- Today's Low: $34.801
- Today's Volume: 348.91K
- Yesterday Close: $34.6
- Yesterday High: $35.65
- Yesterday Low: $34.47
- Yesterday Volume: 2.01M
- Last Min Volume: 4.92K
- Last Min High: $35.36
- Last Min Low: $35.337
- Last Min VWAP: $35.35385
Company Profile
- Name: Arrowhead Research Corporation
- Website: https://www.arrowheadpharma.com
- Listed Date: 1995-02-01
- Location: PASADENA, CA
- Market Status: Active
- CIK Number: 0000879407
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $4.78B
- Round Lot: 100
- Outstanding Shares: 138.26M
- Asset Type: CS
RECENT FILINGS FOR ARWR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-01 | 144 | View |
| 2025-09-16 | 4 | View |
| 2025-09-12 | 144 | View |
| 2025-09-12 | 8-K | View |
| 2025-09-11 | 8-K | View |
| 2025-09-04 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-09-02 | 8-K | View |
| 2025-08-15 | 4 | View |
| 2025-08-15 | SCHEDULE 13D/A | View |
| 2025-08-15 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | 144 | View |
| 2025-08-13 | 144 | View |
| 2025-08-12 | 3 | View |
| 2025-08-11 | SCHEDULE 13G | View |
| 2025-08-07 | 8-K | View |
| 2025-08-07 | 10-Q | View |
| 2025-07-29 | SCHEDULE 13G/A | View |
| 2025-07-10 | 144 | View |
Latest News on ARWR